Steven A. J. Salamon - 13 May 2026 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Reporting relationship: Director
Issuer ticker: DCTH
Reported as of: 13 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 May 2026, 17:45:07 UTC
Prior SEC filing: 19 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Gerard Michel, Attorney-in-Fact

Key filing fact

Steven A. J. Salamon filed Form 4 for DELCATH SYSTEMS, INC. (DCTH) on 14 May 2026.

Key facts

This page summarizes Steven A. J. Salamon's Form 4 filing for DELCATH SYSTEMS, INC. (DCTH).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 May 2026, 17:45.

Change

Previous filing in this sequence was filed on 19 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001623082 Primary reporting owner

SALAMON STEVEN A J

Relationship: Director
Address: 15 WELLESLEY STREET WEST, SUITE 326, TORONTO, ONTARIO, CANADA
Signature: /s/ Gerard Michel, Attorney-in-Fact
Signature date: 14 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DCTH transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +22,500
Change %
Price: $0.000000^*
Shares after: 22,500
Date: 13 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,500
Exercise price: $11.61
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 13, 2026 and monthly thereafter for so long as the reporting person remains a director of the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service.